GLP-1 receptor agonists may interfere with the interpretation of fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET-CT) cancer scans, according to new findings presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results